| Literature DB >> 24522171 |
Matthew R Boylan1, Hamed Khalili1, Edward S Huang2, Dominique S Michaud3, Jacques Izard4, Kaumudi J Joshipura5, Andrew T Chan6.
Abstract
OBJECTIVES: Periodontal disease has been associated with higher circulating levels of inflammatory markers and conditions associated with chronic inflammation, including vascular disease, diabetes mellitus, and cancer. Limited data exist on the relationship between periodontal disease and gastric and duodenal ulcer.Entities:
Year: 2014 PMID: 24522171 PMCID: PMC3940834 DOI: 10.1038/ctg.2013.14
Source DB: PubMed Journal: Clin Transl Gastroenterol ISSN: 2155-384X Impact factor: 4.488
Age-adjusted baseline characteristics of participants in the Health Professionals Follow-up Study according to diagnosis of periodontal disease with bone loss
| Mean (s.d.) age, years | 53.8 (97) | 58.3 (9.2) |
| Non-white race, % | 5 | 7 |
| Dentist, % | 56 | 67 |
| Diabetic, % | 3 | 5 |
| 0–24 | 15 | 29 |
| 25–32 | 85 | 71 |
| <25 | 46 | 43 |
| 25.0–29.9 | 46 | 48 |
| ≥30.0 | 8 | 9 |
| Never | 50 | 30 |
| Past | 42 | 53 |
| Current | 9 | 17 |
| 0.0 | 23 | 21 |
| 0.1–4.9 | 24 | 23 |
| 5.0–14.9 | 29 | 29 |
| ≥15.0 | 24 | 27 |
| Regular user of aspirin | 29 | 30 |
| Regular user of NSAID | 5 | 5 |
Abbreviation: NSAID, non-steroidal anti-inflammatory drug.
Defined as intake ≥2 times/week.
Risk of gastric or duodenal ulcer according to the diagnosis of periodontal disease with bone loss
| Number of cases/person-years | 176/746,133 | 86/190,798 |
| Age-adjusted (95% CI) | 1.00 | 1.66 (1.27–2.16) |
| Multivariate-adjusted | 1.00 | 1.62 (1.24–2.12) |
| Number of cases/person-years | 90/744,014 | 48/190,196 |
| Age-adjusted (95% CI) | 1.00 | 1.85 (1.29–2.65) |
| Multivariate-adjusted | 1.00 | 1.75 (1.21–2.53) |
| Number of cases/person-years | 86/744,029 | 38/190,053 |
| Age-adjusted (95% CI) | 1.00 | 1.47 (0.99–2.18) |
| Multivariate-adjusted | 1.00 | 1.47 (0.98–2.19) |
| H. pylori- | ||
| Number of cases/person-years | 114/746.054 | 59/190,742 |
| Age-adjusted (95% CI) | 1.00 | 1.75 (1.26–2.41) |
| Multivariate-adjusted | 1.00 | 1.75 (1.26–2.43) |
| H. pylori- | ||
| Number of cases/person-years | 62/745,946 | 27/190,720 |
| Age-adjusted (95% CI) | 1.00 | 1.50 (0.94–2.39) |
| Multivariate-adjusted | 1.00 | 1.40 (0.87–2.24) |
| Number of cases/person-years | 401/743,711 | 149/190,337 |
| Age-adjusted (95% CI) | 1.00 | 1.27 (1.05–1.55) |
| Multivariate-adjusted | 1.00 | 1.24 (1.02–1.51) |
Abbreviation: CI, confidence interval.
Models adjusted for age (months), race (white, non-white), profession (non-dental profession, dentist), diabetes (yes, no), body mass index (<25, 25–29.9, ≥30 kg/m2), smoking (never, past, current), alcohol intake (0–4.9, 5–14.9, ≥15 g/day), regular aspirin use (<2, ≥2 times/week), and regular non-steroidal anti-inflammatory drug use (<2, ≥2 times/week).
Sensitivity analysis of all ulcer cases, including those with missing H. pylori data.
Risk of gastric or duodenal ulcer according to tooth loss
| Number of cases/person-years | 203/787,375 | 58/141,770 |
| Age-adjusted (95% CI) | 1.00 | 1.44 (1.06–1.96) |
| Multivariate-adjusted | 1.00 | 1.35 (0.99–1.85) |
| Number of cases/person-years | 108/785,156 | 29/141,296 |
| Age-adjusted (95% CI) | 1.00 | 1.46 (0.95–2.25) |
| Multivariate-adjusted | 1.00 | 1.34 (0.86–2.08) |
| Number of cases/person-years | 95/141,183 | 29/785,122 |
| Age-adjusted (95% CI) | 1.00 | 1.43 (0.93–2.21) |
| Multivariate-adjusted | 1.00 | 1.37 (0.88–2.13) |
Abbreviation: CI, confidence interval.
Reported by participants on baseline questionnaire in 1986.
One case was excluded from both analyses due to missing data on tooth loss at baseline.
Models adjusted for age (months), race (white, non-white), profession (non-dental profession, dentist), diabetes (no, yes), body mass index (<25, 25-29.9, ≥30 kg/m2), smoking (never, past, current), alcohol intake (0–4.9, 5–14.9, ≥15 g/day), regular aspirin use (<2, ≥2 times/week) and regular non-steroidal anti-inflammatory drug use (<2, ≥2 times/week).
Updated biennially beginning in 1988.
Risk of gastric or duodenal ulcer according to diagnosis of periodontal disease with bone loss, stratified by other risk factors for ulcer
| Number of cases/person-years | 85/458,291 | 20/82,983 |
| Age-adjusted (95% CI) | 1.00 | 1.21 (0.74–1.99) |
| Multivariate-adjusted | 1.00 | 1.14 (0.69–1.89) |
| Number of cases/person-years | 91/287,843 | 66/107,815 |
| Age-adjusted (95% CI) | 1.00 | 1.93 (1.40–2.65) |
| Multivariate-adjusted | 1.00 | 1.92 (1.38–2.67) |
| Pheterogeneity=0.11 | ||
| Number of cases/person-years | 63/313,633 | 37/79,011 |
| Age-adjusted (95% CI) | 1.00 | 1.99 (1.30–3.03) |
| Multivariate-adjusted | 1.00 | 2.00 (1.29–3.09) |
| Number of cases/person-years | 113/432,500 | 49/111,787 |
| Age-adjusted (95% CI) | 1.,00 | 1.51 (1.07–2.14) |
| Multivariate-adjusted | 1.00 | 1.43 (1.00–2.03) |
| Pheterogeneity=0.33 | ||
| Number of cases/person-years | 71/301,651 | 26/48,477 |
| Age-adjusted (95% CI) | 1.00 | 2.11 (1.31–3.38) |
| Multivariate-adjusted | 1.00 | 2.14 (1.32–3.47) |
| Number of cases/person-years | 85/277,104 | 46/96,582 |
| Age-adjusted (95% CI) | 1.00 | 1.36 (0.94–1.97) |
| Multivariate-adjusted | 1.00 | 1.34 (0.92–1.95) |
| Pheterogeneity=0.13 | ||
| Number of cases/person-years | 78/358,995 | 33/87,310 |
| Age-adjusted (95% CI) | 1.00 | 1.41 (0.93–2.15) |
| Multivariate-adjusted | 1.00 | 1.47 (0.95–2.25) |
| Number of cases/person-years | 98/387,138 | 53/103,488 |
| Age-adjusted (95% CI) | 1.00 | 1.84 (1.30–2.60) |
| Multivariate-adjusted | 1.00 | 1.76 (1.23–2.51) |
| Pheterogeneity=0.53 | ||
| Number of cases/person-years | 47/363,369 | 30/84,842 |
| Age-adjusted (95% CI) | 1.00 | 2.11 (1.31–3.42) |
| Multivariate-adjusted | 1.00 | 2.08 (1.26–3.43) |
| Number of cases/person-years | 129/382,765 | 56/105,956 |
| Age-adjusted (95% CI) | 1.00 | 1.47 (1.06–2.03) |
| Multivariate-adjusted | 1.00 | 1.42 (1.02–1.97) |
| Pheterogeneity=0.10 | ||
| Number of cases/person-years | 86/325,252 | 38/70,615 |
| Age-adjusted (95% CI) | 1.00 | 1.73 (1.16–2.58) |
| Multivariate-adjusted | 1.00 | 1.69 (1.12–2.54) |
| Number of cases/person-years | 90/420,881 | 48/120,183 |
| Age-adjusted (95% CI) | 1.00 | 1.72 (1.20–2.48) |
| Multivariate-adjusted | 1.00 | 1.66 (1.14–2.41) |
| Pheterogeneity=0.74 | ||
Abbreviations: CI, confidence interval; NSAID, non-steroidal anti-inflammatory drug.
Models adjusted for age (months), race (white, non-white), profession (non-dental profession, dentist), diabetes (no, yes), body mass index (<25, 25–29.9, ≥30 kg/m2), smoking (never, past, current), alcohol intake (0–4.9, 5–14.9, ≥15 g/day), regular aspirin use (<2, ≥2 times/week), and regular NSAID use (<2, ≥2 times/week). For each stratified analysis, the variable for the strata of interest was omitted.
Non-regular aspirin or NSAID user was defined as intake of aspirin or NSAIDs <2 times/week. Regular aspirin or NSAID user was defined as intake of aspirin or NSAIDs ≥2 times/week.